DOT associated with reduced all-cause mortality among tuberculosis patients in Taipei, Taiwan, 2006-2008

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 2, 2012, Pages 178-184

  Yen, Y F ^a,b   Rodwell, T C ^b   Yen, M Y ^a   Shih, H C ^a   Hu, B S ^a   Li, L H ^a   Shie, Y H ^a   Chuang, P ^a   Garfein, Richard S ^b  

^a TAIPEI CITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Directly observed therapy; Mortality; Treatment; Tuberculosis

Indexed keywords

ACID FAST BACTERIUM; ADULT; AGE; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; DISEASE SEVERITY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; IMMIGRANT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PLEURA EFFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TAIWAN; TUBERCULOSIS; UNEMPLOYMENT;

AGED; ANTITUBERCULAR AGENTS; CAUSE OF DEATH; DIRECTLY OBSERVED THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TAIWAN; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84862911475     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0034     Document Type: Article

References (29)

1. World Health Organization. Global tuberculosis control report 2010. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010. http://www.who.int/tb/ publications/global-report/2010/en/index.html Accessed November 2011.
2. Taiwan Centers for Disease Control and Prevention. [Promulgated definitions of TB]. Taipei, Taiwan: CDC, 2009. http://203.65.72.83/ch/dt/upload/ QC/QC-index.htm Accessed November 2011. [Chinese]
3. Stop TB Partnership and World Health Organization. Global plan to stop TB 2006-2015. Geneva, Switzerland: WHO, 2006.
4. Walley J D, Khan M A, Newell J N, Khan M H. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001; 357: 664-669. (Pubitemid 32206424)
5. Newell J N, Baral S C, Pande S B, Bam D S, Malla P. Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 2006; 367: 903-909.
6. Wright J, Walley J, Philip A, et al. Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop Med Int Health 2004; 9: 559-565. (Pubitemid 38657280)
7. Wandwalo E, Kapalata N, Egwaga S, Morkve O. Effectiveness of community-based directly observed treatment for tuberculosis in an urban setting in Tanzania: a randomised controlled trial. Int J Tuberc Lung Dis 2004; 8: 1248-1254. (Pubitemid 39371839)
8. MacIntyre C R, Goebel K, Brown G V, Skull S, Starr M, Fullinfaw R O. A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting. Int J Tuberc Lung Dis 2003; 7: 848-854. (Pubitemid 37158423)
9. Lwilla F, Schellenberg D, Masanja H, et al. Evaluation of efficacy of community-based vs. institutional-based direct observed short-course treatment for the control of tuberculosis in Kilombero District, Tanzania. Trop Med Int Health 2003; 8: 204-210. (Pubitemid 36398804)
10. Zwarenstein M, Schoeman J H, Vundule C, Lombard C J, Tatley M. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. Int J Tuberc Lung Dis 2000; 4: 550-554. (Pubitemid 30409172)
11. Kamolratanakul P, Sawert H, Lertmaharit S, et al. Randomized controlled trial of directly observed treatment (DOT) for patients with pulmonary tuberculosis in Thailand. Trans R Soc Trop Med Hyg 1999; 93: 552-557. (Pubitemid 29495849)
12. Zwarenstein M, Schoeman J H, Vundule C, Lombard C J, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998; 352: 1340-1343. (Pubitemid 28510914)
13. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2009: CD003343.
14. Caylà J A, Caminero J A, Rey R, Lara N, Vallés X, Galdós-Tangüis H. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberc Lung Dis 2004; 8: 458-464. (Pubitemid 38624855)
15. Jasmer R M, Seaman C B, Gonzalez L C, Kawamura L M, Osmond D H, Daley C L. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2004; 170: 561-566. (Pubitemid 39209140)
16. Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U. Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five-year retrospective study. BMC Public Health 2009; 9: 371.
17. Kliiman K, Altraja A. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14: 454-463.
18. Nahid P, Jarlsberg L G, Rudoy I, et al. Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis 2011; 11: 1.
19. World Health Organization. WHO report on the tuberculosis epidemic, 1995. Stop TB at the source. WHO/TB/95.183. Geneva, Switzerland: WHO, 1995.
20. Frieden T R, Sbarbaro J A. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull World Health Organ 2007; 85: 407-409.
21. Pungrassami P, Johnsen S P, Chongsuvivatwong V, Olsen J, S ørensen H T. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 2002; 6: 389-395. (Pubitemid 34492162)
22. Mathema B, Pande S B, Jochem K, et al. Tuberculosis treatment in Nepal: a rapid assessment of government centers using different types of patient supervision. Int J Tuberc Lung Dis 2001; 5: 912-919. (Pubitemid 32976635)
23. Lin H P, Deng C Y, Chou P. Diagnosis and treatment delay among pulmonary tuberculosis patients identified using the Taiwan reporting enquiry system, 2002-2006. BMC Public Health 2009; 9: 55.
24. Cheng S H, Chiang T L. The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA 1997; 278: 89-93.
25. Chiang C-Y, Lee J-J, Yu M-C, Enarson D A, Lin T-P, Luh K-T. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis 2009; 13: 105-111.
26. Falzon D, Le Strat Y, Belghiti F, Infuso A. Exploring the determinants of treatment success for tuberculosis cases in Europe. Int J Tuberc Lung Dis 2005; 9: 1224-1229. (Pubitemid 41735601)
27. Dewan P K, Arguin P M, Kiryanova H, et al. Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis 2004; 8: 598-602. (Pubitemid 38625066)
28. Albalak R, O'Brien R J, Kammerer J S, et al. Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004. Arch Intern Med 2007; 167: 2443-2452. (Pubitemid 350254903)
29. Ahmed A B, Abubakar I, Delpech V, et al. The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999-2003. Thorax 2007; 62: 672-676. (Pubitemid 47235006)